Insider trade

Tandem Diabetes Care (TNDM): CFO bought ~$149K

Leigh Vosseller, CFO at Tandem Diabetes Care, bought ~$149K of Tandem Diabetes Care shares.

~$149K
Approx. value · 14K sh @ $10.89
26K
Holds after · shares reported
Traded
Aug 8, 2025
Filed
Aug 11, 2025

What stands out in this filing

  • The purchase added 115.7% to the shares this insider held before it; the filing reports 25,580 shares, held indirectly afterwards.
  • 13,720 shares at an average of $10.89 each, as reported on the form.
  • 1 other insider at TNDM also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 8, 2025 · this disclosureInsiderCFO purchased ~$149K of TNDM shares in the open market

What came next

  1. Aug 11, 2025InsiderCEO purchased ~$102K of TNDM shares in the open market
  2. Sep 22, 2025CongressDisclosed purchase of TNDM — reported range $1,001 - $15,000
  3. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 7, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 7, 2025, the Board of Directors (the “Board”) of Tandem Diabetes Care, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from eight to nine directors and appointed Sandra Beaver, age 48, to serve as a member of the Board, with a term of office that expires at the Annual Meeting of Stockholders of the Company to…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tandem Diabetes Care

For Tandem Diabetes Care, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TNDM page.

How this filing works

Explore the data

Common questions

Which Tandem Diabetes Care (TNDM) insider traded, and how much?

Leigh Vosseller, CFO at Tandem Diabetes Care, bought ~$149K of Tandem Diabetes Care shares. 14K shares at $10.89, open market.

When did it happen, and when was it made public?

Traded: Aug 8, 2025. Filed: Aug 11, 2025. That is 3 days between the two dates.

What stands out in this filing?

The purchase added 115.7% to the shares this insider held before it; the filing reports 25,580 shares, held indirectly afterwards. 13,720 shares at an average of $10.89 each, as reported on the form. 1 other insider at TNDM also bought in the open market within 30 days.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Tandem Diabetes Care recently?

For Tandem Diabetes Care, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the TNDM page.

Does this mean TNDM stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tandem Diabetes Care

Everything OQRO holds on this company is on its TNDM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data